Cancer.Net Associate Editors share important new research from the 2018 ASCO Annual Meeting that can help improve the quality of life for people living with cancer.
Losing a loved one to cancer is hard. Learn how Valerie Guild is honoring her daughter’s life by working to save the lives of others through advocacy.
“Even after I heard horror stories about the negative effects of indoor tanning, I knew they’d never happen to me. I couldn’t have been more wrong.” Ashley Drury shares her journey from tanning bed advocate to survivor of advanced melanoma.
Cancer.Net’s Associate Editors discuss the most exciting research presented at the 2017 ASCO Annual Meeting.
Cancer survivor Bryant Wieneke describes his experience receiving immunotherapy to treat metastatic melanoma.
In this Voices on Cancer post, patient advocate Gilliosa Spurrier Bernard shares her experience advocating for people with melanoma in France.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
Wrapping up our summer Research Round Up series, experts discuss advances in lung cancer and melanoma research.